Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pegfilgrastim”

159 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 159 results

Testing effectiveness (Phase 2)Ended earlyNCT01639131
What this trial is testing

Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma

Who this might be right for
Metastatic Colorectal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Not applicableStudy completedNCT00615901
What this trial is testing

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT01169636
What this trial is testing

Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma

Who this might be right for
Hodgkin's Lymphoma
M.D. Anderson Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT00066092
What this trial is testing

Pegfilgrastim PBPC Mobilization Study

Who this might be right for
LymphomaHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more
Amgen 41
Early research (Phase 1)Study completedNCT00612989
What this trial is testing

Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM

Who this might be right for
GlioblastomaGliosarcoma
Duke University 42
Large-scale testing (Phase 3)Study completedNCT00602420
What this trial is testing

Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)

Who this might be right for
Musculoskeletal ComplicationsPainUnspecified Adult Solid Tumor, Protocol Specific
Gary Morrow 510
Testing effectiveness (Phase 2)Study completedNCT00067639
What this trial is testing

Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT01682044
What this trial is testing

Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma

Who this might be right for
Contiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Grade 3 Follicular Lymphoma+30 more
Roswell Park Cancer Institute 20
Large-scale testing (Phase 3)Study completedNCT01735175
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

Who this might be right for
Neutropenic ComplicationsBreast NeoplasmsChemotherapy-induced Neutropenia+1 more
Sandoz 316
Early research (Phase 1)Study completedNCT03376503
What this trial is testing

Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

Who this might be right for
Breast Cancer
Nanogen Pharmaceutical Biotechnology Joint Stock Company 24
Testing effectiveness (Phase 2)Study completedNCT01557959
What this trial is testing

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more
Wake Forest University Health Sciences 45
Large-scale testing (Phase 3)Study completedNCT03102606
What this trial is testing

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 105
Not applicableStudy completedNCT02527317
What this trial is testing

Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast Cancer

Who this might be right for
Breast Cancer
Beaumont Hospital 40
Early research (Phase 1)Study completedNCT00352300
What this trial is testing

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

Who this might be right for
Fallopian Tube CarcinomaInfectious DisorderNeutropenia+4 more
Gynecologic Oncology Group 43
Not applicableLooking for participantsNCT05841186
What this trial is testing

Correlation of Timing of Pegfilgrastim Administration and PIBP.

Who this might be right for
PegfilgrastimBone PainChemotherapy+3 more
Guangdong Provincial People's Hospital 156
Early research (Phase 1)Study completedNCT02912377
What this trial is testing

Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects

Who this might be right for
Healthy Volunteers
Cinfa Biotech 96
Large-scale testing (Phase 3)Study completedNCT03252431
What this trial is testing

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 393
Large-scale testing (Phase 3)Study completedNCT01516736
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Who this might be right for
Chemotherapy-induced NeutropeniaBreast Cancer
Sandoz 308
Large-scale testing (Phase 3)Study completedNCT05283616
What this trial is testing

Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer

Who this might be right for
Neutropenia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 122
Post-approval studies (Phase 4)Study completedNCT02782845
What this trial is testing

An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 53
Load More Results